Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug

Author： Pan Dipanjan   Sanyal Nibedita   Schmieder Anne H   Senpan Angana   Kim Benjamin   Yang Xiaoxia   Hu Grace   Allen John S   Gross Richard W   Wickline Samuel A   Lanza Gregory M  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.7, Iss.10, 2012-10, pp. : 1507-1519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiangiogenic nanotherapy for the control of obesity

By Kajimoto Kazuaki   Hossen Nazir   Harashima Hideyoshi  

Nanomedicine, Vol. 8, Iss. 5, 2013-05 ,pp. : 671-673

Future Medicine

Access to resources Recommend Favorite

Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis

By Zhou Hui-fang   Hu Grace   Wickline Samuel A   Lanza Gregory M   Pham Christine TN  

Nanomedicine, Vol. 5, Iss. 7, 2010-09 ,pp. : 1065-1074

Future Medicine

Access to resources Recommend Favorite

Incorporation of capric acid in pumpkin seed oil by sn-1,3 regioselective lipase-catalyzed acidolysis

By Sousa Vanessa   Campos Vitor   Nunes Patrícia   Pires-Cabral Paula  

OCL (Oilseeds, Crops, fats & Lipids), Vol. 25, Iss. 3, 2018-06 ,pp. : A302-A302

Edp Sciences

Access to resources Recommend Favorite

Advances and Perspectives in Cancer Nanotherapy: The Added- Value of Nanocarriers

By  

Current Nanomedicine, Vol. 7, Iss. 3, 2017-09 ,pp. : 170-190

Bentham Science Publishers

Access to resources Recommend Favorite

Anti‐angiogenic activity of thienopyridine derivative LCB03‐0110 by targeting VEGFR‐2 and JAK/STAT3 Signalling

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 7, 2015-07 ,pp. : 503-509

John Wiley & Sons Inc

Access to resources Recommend Favorite